United States Government Publishing Office publisher pbl distributor dst United States National Archives and Records Administration Office of the Federal Register author aut Government Organization text government publication eng FR Regulatory Information 2023_register executive 2023-10-27 article Notices D09002ee1c796c61b D09002ee1c796c6f7 United States Environmental Protection Agency originator org United States Government Agency or Subagency The Environmental Protection Agency (EPA) is announcing the availability of and soliciting comment on the near-term strategies described in this document to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, among other things, that EPA screen for and protect against endocrine disrupting effects in humans. An important part of these obligations and commitments is the Endocrine Disruptor Screening Program (EDSP), which EPA established in 1998 as a two-tier endocrine screening and testing process for pesticides and other chemicals. After over two decades of implementing the EDSP and other aspects of the mandate in FFDCA, EPA has developed near-term strategies to begin addressing the challenges it has encountered and to rebuild the EDSP. This document covers only the initial strategies that EPA is taking over the next several years to generate momentum toward its longer-term goal of timely addressing all its endocrine screening data needs and decisions. Through this notice and to help implement its strategies, EPA is also seeking additional endocrine data on two groups of active ingredients currently undergoing registration review, or explanations of why the additional data are unnecessary for EPA to make its FIFRA and FFDCA decisions. 88 FR 73841 https://www.govinfo.gov/app/details/FR-2023-10-27/2023-23721 2023-23721 fr27oc23-38 6560-50-P EPA-HQ-OPP-2023-0474 FRL-11384-01-OCSPP https://www.govinfo.gov/app/details/FR-2023-10-27/2023-23721 https://www.govinfo.gov/content/pkg/FR-2023-10-27/html/2023-23721.htm https://www.govinfo.gov/content/pkg/FR-2023-10-27/pdf/2023-23721.pdf 13 p. 73841 73853 88 FR 73841 Endocrine Disruptor Screening Program (EDSP); Near-Term Strategies for Implementation; Notice of Availability and Request for Comment; Federal Register Vol. 88, Issue NOTICE 2023-23721 ENVIRONMENTAL PROTECTION AGENCY 2023-12-26 EPA-HQ-OPP-2023-0474 FRL-11384-01-OCSPP 6560-50-P 2023-23721 Notice.

The Environmental Protection Agency (EPA) is announcing the availability of and soliciting comment on the near-term strategies described in this document to help the Agency meet its obligations and commitments under the Federal Food, Drug, and Cosmetic Act (FFDCA), which requires, among other things, that EPA screen for and protect against endocrine disrupting effects in humans. An important part of these obligations and commitments is the Endocrine Disruptor Screening Program (EDSP), which EPA established in 1998 as a two-tier endocrine screening and testing process for pesticides and other chemicals. After over two decades of implementing the EDSP and other aspects of the mandate in FFDCA, EPA has developed near-term strategies to begin addressing the challenges it has encountered and to rebuild the EDSP. This document covers only the initial strategies that EPA is taking over the next several years to generate momentum toward its longer-term goal of timely addressing all its endocrine screening data needs and decisions. Through this notice and to help implement its strategies, EPA is also seeking additional endocrine data on two groups of active ingredients currently undergoing registration review, or explanations of why the additional data are unnecessary for EPA to make its FIFRA and FFDCA decisions.

Comments must be received on or before December 26, 2023. Catherine Aubee, Endocrine Disruptor Screening Program (7505T), Office of Pesticide Programs, Environmental Protection Agency, 1200 Pennsylvania Ave. NW, Washington, DC 20460- Endocrine Disruptor Screening Program: Near-Term Strategies for Implementation, pesticidequestions@epa.gov https://cdx.epa.gov/ https://www.epa.gov/ https://www.epa.gov//commenting-epa-dockets https://www.epa.gov/dockets/commenting-epa-dockets#rules https://www.epa.gov/endangered-species/epas-workplan-and-progress-toward-better-protections-endangered-species https://www.epa.gov/sites/default/files/2015-06/documents/thyroid_guidance_assay.pdf https://www.epa.gov/sites/default/files/2015-08/documents/122898frnotice.pdf https://www.epaoig.gov/reports/audit/epas-endocrine-disruptor-screening-program-has-made-limited-progress-assessing https://www.oecd-ilibrary.org/docserver/9789264070684-en.pdf?expires=1695669052&id=id&accname=guest&checksum=B2CCC35058D14B03AFA5C29EBB5D1CE5 https://www.oecd-ilibrary.org/docserver/9789264070707-en.pdf?expires=1695668998&id=id&accname=guest&checksum=19E7679541E3927AE5066BBB8CFA0F54 https://www.oecd-ilibrary.org/docserver/9789264185371-en.pdf?expires=1695671098&id=id&accname=guest&checksum=F8B12F13B2F19A2731C51FA392B78716 https://www.regulations.gov https://www.regulations.gov/document/EPA-HQ-OPP-2011-0448-0076 https://www.regulations.gov/document/EPA-HQ-OPP-2020-0558-0008 https://www.regulations.gov/document/EPA-HQ-OPP-2021-0756-0002 https://www.regulations.gov/document/EPA-HQ-OPPT-2009-0156-0018 Vol. 88, no. 207 Office of the Federal Register, National Archives and Records Administration 2023-10-27 continuing daily deposited born digital 274 p. Table of Contents: AE 2.7: GS 4.107: AE 2.106: KF70.A2 https://www.govinfo.gov/app/details/FR-2023-10-27 P0b002ee1c1ba3377 0097-6326 0042-1219 0364-1406 769-004-00000-9 000582072 f:fr27oc23 https://www.govinfo.gov/app/details/FR-2023-10-27 https://www.govinfo.gov/content/pkg/FR-2023-10-27/pdf/FR-2023-10-27.pdf https://www.govinfo.gov/content/pkg/FR-2023-10-27/xml/FR-2023-10-27.xml fdlp 73755 74018 DGPO 2023-10-27 2024-05-28 FR-2023-10-27 machine generated eng FR FR-2023-10-27 88 207